ID   AT8A1_HUMAN             Reviewed;        1164 AA.
AC   Q9Y2Q0; Q32M35; Q32M36; Q4W5J7; Q4W5P2;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   12-APR-2017, entry version 161.
DE   RecName: Full=Phospholipid-transporting ATPase IA;
DE            EC=3.6.3.1;
DE   AltName: Full=ATPase class I type 8A member 1;
DE   AltName: Full=Chromaffin granule ATPase II;
DE   AltName: Full=P4-ATPase flippase complex alpha subunit ATP8A1;
GN   Name=ATP8A1; Synonyms=ATPIA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Skeletal muscle;
RX   PubMed=10198212; DOI=10.1006/bbrc.1999.0347;
RA   Mouro I., Halleck M.S., Schlegel R.A., Mattei M.-G., Williamson P.L.,
RA   Zachowski A., Devaux P., Cartron J.-P., Colin Y.;
RT   "Cloning, expression, and chromosomal mapping of a human ATPase II
RT   gene, member of the third subfamily of P-type ATPases and orthologous
RT   to the presumed bovine and murine aminophospholipid translocase.";
RL   Biochem. Biophys. Res. Commun. 257:333-339(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-1164 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Osada S., Nakanishi Y.;
RT   "cDNA cloning of human ATPaseII.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   INTERACTION WITH TMEM30A, AND SUBCELLULAR LOCATION.
RX   PubMed=20947505; DOI=10.1074/jbc.M110.139006;
RA   van der Velden L.M., Wichers C.G., van Breevoort A.E., Coleman J.A.,
RA   Molday R.S., Berger R., Klomp L.W., van de Graaf S.F.;
RT   "Heteromeric interactions required for abundance and subcellular
RT   localization of human CDC50 proteins and class 1 P4-ATPases.";
RL   J. Biol. Chem. 285:40088-40096(2010).
RN   [9]
RP   INTERACTION WITH TMEM30A AND TMEM30B.
RX   PubMed=20961850; DOI=10.1074/jbc.M110.139543;
RA   Bryde S., Hennrich H., Verhulst P.M., Devaux P.F., Lenoir G.,
RA   Holthuis J.C.;
RT   "CDC50 proteins are critical components of the human class-1 P4-ATPase
RT   transport machinery.";
RL   J. Biol. Chem. 285:40562-40572(2010).
RN   [10]
RP   INTERACTION WITH TMEM30A, AND SUBCELLULAR LOCATION.
RX   PubMed=21914794; DOI=10.1074/jbc.M111.281006;
RA   Takatsu H., Baba K., Shima T., Umino H., Kato U., Umeda M.,
RA   Nakayama K., Shin H.W.;
RT   "ATP9B, a P4-ATPase (a putative aminophospholipid translocase),
RT   localizes to the trans-Golgi network in a CDC50 protein-independent
RT   manner.";
RL   J. Biol. Chem. 286:38159-38167(2011).
CC   -!- FUNCTION: Catalytic component of a P4-ATPase flippase complex
CC       which catalyzes the hydrolysis of ATP coupled to the transport of
CC       aminophospholipids from the outer to the inner leaflet of various
CC       membranes and ensures the maintenance of asymmetric distribution
CC       of phospholipids. Phospholipid translocation seems also to be
CC       implicated in vesicle formation and in uptake of lipid signaling
CC       molecules. In vitro, its ATPase activity is selectively and
CC       stereospecifically stimulated by phosphatidylserine (PS). The
CC       flippase complex ATP8A1:TMEM30A seems to play a role in regulation
CC       of cell migration probably involving flippase-mediated
CC       translocation of phosphatidylethanolamine (PE) at the plasma
CC       membrane. Acts as aminophospholipid translocase at the plasma
CC       membrane in neuronal cells.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + phospholipid(Side 1) = ADP +
CC       phosphate + phospholipid(Side 2).
CC   -!- ENZYME REGULATION: ATPase activity is stimulated by
CC       phosphatidylserine (PS) and minimally by phosphatidylethanolamine
CC       (PE). {ECO:0000250}.
CC   -!- SUBUNIT: Component of a P4-ATPase flippase complex which consists
CC       of a catalytic alpha subunit and an accessory beta subunit.
CC       Interacts with TMEM30A to form a flippase complex; the interaction
CC       with TMEM30B is reported conflictingly.
CC       {ECO:0000269|PubMed:20947505, ECO:0000269|PubMed:20961850,
CC       ECO:0000269|PubMed:21914794}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle,
CC       chromaffin granule membrane {ECO:0000250|UniProtKB:P70704}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:P70704}. Cytoplasmic
CC       granule {ECO:0000269|PubMed:20947505}. Cell membrane
CC       {ECO:0000269|PubMed:20947505, ECO:0000269|PubMed:21914794}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:20947505,
CC       ECO:0000269|PubMed:21914794}. Golgi apparatus
CC       {ECO:0000269|PubMed:20947505, ECO:0000269|PubMed:21914794}.
CC       Note=Exit from the endoplasmic reticulum requires the presence of
CC       TMEM30A, but not TMEM30B (PubMed:20947505). In the presence of
CC       TMEM30A, predominantly located in cytoplasmic punctate structures
CC       and localizes to the plasma membrane (PubMed:20947505). Localizes
CC       to plasma membranes of red blood cells (By similarity).
CC       {ECO:0000250|UniProtKB:P70704, ECO:0000269|PubMed:20947505}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q9Y2Q0-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=Q9Y2Q0-2; Sequence=VSP_000431;
CC       Name=3;
CC         IsoId=Q9Y2Q0-3; Sequence=VSP_040977, VSP_000431;
CC   -!- TISSUE SPECIFICITY: Found in most adult tissues except liver,
CC       testis and placenta. Most abundant in heart, brain and skeletal
CC       muscle. Also detected in fetal tissues. Isoform 1 is only detected
CC       in brain, skeletal muscle and heart and is the most abundant form
CC       in skeletal muscle.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IV subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI09318.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA77248.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF067820; AAD34706.1; -; mRNA.
DR   EMBL; AC084010; AAY40980.1; -; Genomic_DNA.
DR   EMBL; AC096734; AAY40924.1; -; Genomic_DNA.
DR   EMBL; AC110788; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139717; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471069; EAW93003.1; -; Genomic_DNA.
DR   EMBL; BC109317; AAI09318.1; ALT_INIT; mRNA.
DR   EMBL; BC109318; AAI09319.1; -; mRNA.
DR   EMBL; AB013452; BAA77248.1; ALT_INIT; mRNA.
DR   CCDS; CCDS3466.1; -. [Q9Y2Q0-1]
DR   CCDS; CCDS47049.1; -. [Q9Y2Q0-3]
DR   RefSeq; NP_001098999.1; NM_001105529.1. [Q9Y2Q0-3]
DR   RefSeq; NP_006086.1; NM_006095.2. [Q9Y2Q0-1]
DR   RefSeq; XP_016863134.1; XM_017007645.1. [Q9Y2Q0-2]
DR   UniGene; Hs.435052; -.
DR   ProteinModelPortal; Q9Y2Q0; -.
DR   BioGrid; 115668; 2.
DR   IntAct; Q9Y2Q0; 1.
DR   STRING; 9606.ENSP00000371084; -.
DR   DrugBank; DB00144; Phosphatidyl serine.
DR   TCDB; 3.A.3.8.13; the p-type atpase (p-atpase) superfamily.
DR   iPTMnet; Q9Y2Q0; -.
DR   PhosphoSitePlus; Q9Y2Q0; -.
DR   BioMuta; ATP8A1; -.
DR   DMDM; 8134331; -.
DR   MaxQB; Q9Y2Q0; -.
DR   PaxDb; Q9Y2Q0; -.
DR   PeptideAtlas; Q9Y2Q0; -.
DR   PRIDE; Q9Y2Q0; -.
DR   Ensembl; ENST00000264449; ENSP00000264449; ENSG00000124406. [Q9Y2Q0-3]
DR   Ensembl; ENST00000381668; ENSP00000371084; ENSG00000124406. [Q9Y2Q0-1]
DR   GeneID; 10396; -.
DR   KEGG; hsa:10396; -.
DR   UCSC; uc003gwr.3; human. [Q9Y2Q0-1]
DR   CTD; 10396; -.
DR   DisGeNET; 10396; -.
DR   GeneCards; ATP8A1; -.
DR   HGNC; HGNC:13531; ATP8A1.
DR   HPA; HPA049948; -.
DR   HPA; HPA052935; -.
DR   MIM; 609542; gene.
DR   neXtProt; NX_Q9Y2Q0; -.
DR   OpenTargets; ENSG00000124406; -.
DR   PharmGKB; PA25165; -.
DR   eggNOG; ENOG410ITKD; Eukaryota.
DR   eggNOG; ENOG410XPYK; LUCA.
DR   GeneTree; ENSGT00870000136387; -.
DR   HOGENOM; HOG000202528; -.
DR   HOVERGEN; HBG050601; -.
DR   InParanoid; Q9Y2Q0; -.
DR   KO; K14802; -.
DR   OMA; KDLDMHY; -.
DR   OrthoDB; EOG091G0139; -.
DR   PhylomeDB; Q9Y2Q0; -.
DR   TreeFam; TF300654; -.
DR   BRENDA; 3.6.3.1; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   ChiTaRS; ATP8A1; human.
DR   GenomeRNAi; 10396; -.
DR   PRO; PR:Q9Y2Q0; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000124406; -.
DR   CleanEx; HS_ATP8A1; -.
DR   ExpressionAtlas; Q9Y2Q0; baseline and differential.
DR   Genevisible; Q9Y2Q0; HS.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0042584; C:chromaffin granule membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0005802; C:trans-Golgi network; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019829; F:cation-transporting ATPase activity; NAS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004012; F:phospholipid-translocating ATPase activity; IBA:GO_Central.
DR   GO; GO:0048194; P:Golgi vesicle budding; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045332; P:phospholipid translocation; NAS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0061092; P:positive regulation of phospholipid translocation; IEA:Ensembl.
DR   Gene3D; 2.70.150.10; -; 1.
DR   Gene3D; 3.40.1110.10; -; 2.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006539; P-type_ATPase_IV.
DR   InterPro; IPR032631; P-type_ATPase_N.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR032630; P_typ_ATPase_c.
DR   PANTHER; PTHR24092; PTHR24092; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   Pfam; PF16212; PhoLip_ATPase_C; 1.
DR   Pfam; PF16209; PhoLip_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 3.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01652; ATPase-Plipid; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 3.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Cytoplasmic vesicle; Endoplasmic reticulum; Golgi apparatus;
KW   Hydrolase; Lipid transport; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1164       Phospholipid-transporting ATPase IA.
FT                                /FTId=PRO_0000046360.
FT   TOPO_DOM      1     65       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     66     86       Helical. {ECO:0000255}.
FT   TOPO_DOM     87     92       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM     93    115       Helical. {ECO:0000255}.
FT   TOPO_DOM    116    297       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    298    319       Helical. {ECO:0000255}.
FT   TOPO_DOM    320    344       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM    345    366       Helical. {ECO:0000255}.
FT   TOPO_DOM    367    857       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    858    878       Helical. {ECO:0000255}.
FT   TOPO_DOM    879    890       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM    891    910       Helical. {ECO:0000255}.
FT   TOPO_DOM    911    940       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    941    962       Helical. {ECO:0000255}.
FT   TOPO_DOM    963    976       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM    977    999       Helical. {ECO:0000255}.
FT   TOPO_DOM   1000   1005       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1006   1026       Helical. {ECO:0000255}.
FT   TOPO_DOM   1027   1044       Exoplasmic loop. {ECO:0000255}.
FT   TRANSMEM   1045   1070       Helical. {ECO:0000255}.
FT   TOPO_DOM   1071   1164       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     741    748       ATP. {ECO:0000255}.
FT   NP_BIND    1095   1102       ATP. {ECO:0000255}.
FT   ACT_SITE    409    409       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   METAL       801    801       Magnesium. {ECO:0000250}.
FT   METAL       805    805       Magnesium. {ECO:0000250}.
FT   MOD_RES      25     25       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087}.
FT   MOD_RES      28     28       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P70704}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70704}.
FT   MOD_RES     443    443       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70704}.
FT   MOD_RES    1126   1126       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70704}.
FT   VAR_SEQ     152    171       AVGEIVKVTNGEHLPADLIS -> NVGDIVIIKGKEYIPAD
FT                                TVL (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040977.
FT   VAR_SEQ     433    447       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10198212,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000431.
FT   VARIANT     673    673       T -> M (in dbSNP:rs3792687).
FT                                /FTId=VAR_022003.
FT   CONFLICT    364    364       E -> K (in Ref. 4; BAA77248).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1164 AA;  131369 MW;  CE1EAF0206CD36F7 CRC64;
     MPTMRRTVSE IRSRAEGYEK TDDVSEKTSL ADQEEVRTIF INQPQLTKFC NNHVSTAKYN
     IITFLPRFLY SQFRRAANSF FLFIALLQQI PDVSPTGRYT TLVPLLFILA VAAIKEIIED
     IKRHKADNAV NKKQTQVLRN GAWEIVHWEK VAVGEIVKVT NGEHLPADLI SLSSSEPQAM
     CYIETSNLDG ETNLKIRQGL PATSDIKDVD SLMRISGRIE CESPNRHLYD FVGNIRLDGH
     GTVPLGADQI LLRGAQLRNT QWVHGIVVYT GHDTKLMQNS TSPPLKLSNV ERITNVQILI
     LFCILIAMSL VCSVGSAIWN RRHSGKDWYL NLNYGGASNF GLNFLTFIIL FNNLIPISLL
     VTLEVVKFTQ AYFINWDLDM HYEPTDTAAM ARTSNLNEEL GQVKYIFSDK TGTLTCNVMQ
     FKKCTIAGVA YGHVPEPEDY GCSPDEWQNS QFGDEKTFSD SSLLENLQNN HPTAPIICEF
     LTMMAVCHTA VPEREGDKII YQAASPDEGA LVRAAKQLNF VFTGRTPDSV IIDSLGQEER
     YELLNVLEFT SARKRMSVIV RTPSGKLRLY CKGADTVIYD RLAETSKYKE ITLKHLEQFA
     TEGLRTLCFA VAEISESDFQ EWRAVYQRAS TSVQNRLLKL EESYELIEKN LQLLGATAIE
     DKLQDQVPET IETLMKADIK IWILTGDKQE TAINIGHSCK LLKKNMGMIV INEGSLDGTR
     ETLSRHCTTL GDALRKENDF ALIIDGKTLK YALTFGVRQY FLDLALSCKA VICCRVSPLQ
     KSEVVEMVKK QVKVVTLAIG DGANDVSMIQ TAHVGVGISG NEGLQAANSS DYSIAQFKYL
     KNLLMIHGAW NYNRVSKCIL YCFYKNIVLY IIEIWFAFVN GFSGQILFER WCIGLYNVMF
     TAMPPLTLGI FERSCRKENM LKYPELYKTS QNALDFNTKV FWVHCLNGLF HSVILFWFPL
     KALQYGTAFG NGKTSDYLLL GNFVYTFVVI TVCLKAGLET SYWTWFSHIA IWGSIALWVV
     FFGIYSSLWP AIPMAPDMSG EAAMLFSSGV FWMGLLFIPV ASLLLDVVYK VIKRTAFKTL
     VDEVQELEAK SQDPGAVVLG KSLTERAQLL KNVFKKNHVN LYRSESLQQN LLHGYAFSQD
     ENGIVSQSEV IRAYDTTKQR PDEW
//
